Ep. 119: Phase 2 HOPE clinical trial results

Moderator: Theodoros M. Mavridis (Dublin, Ireland) Guest: Messoud Ashina (Glostrup, Denmark) In this episode Theodoros M. Mavridis and Messoud Ashina delve into the findings of the Phase 2 HOPE clinical trial, which assesses the efficacy and safety of Lu AG09222, a monoclonal antibody that targets the PACAP pathway. They explore the potential of this innovative treatment for migraine prevention while highlighting the critical role of the PACAP pathway in migraine pathophysiology.

Om Podcasten

eanCast: Weekly Neurology is your source for education, research and updates from the European Academy of Neurology. Regardless of experience level, you are invited to join expert moderators and guests in reviewing, discussing, and debating various topics within the 29 EAN sub-specialties. New neurological topics every month, and new episodes every Monday.